Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)

Clinical trial NCT01584115 · UNKNOWN

Trial details

NCT number: NCT01584115
Sponsor: Instituto de Investigação em Imunologia
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer.Melanoma.Ovarian Cancer.Lung Cancer.

Start date: 2012-07-01
Primary completion: 2013-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.